BRPI0803636A2 - processo para a sìntese de ranelato de estrÈncio e seus hidratos - Google Patents

processo para a sìntese de ranelato de estrÈncio e seus hidratos

Info

Publication number
BRPI0803636A2
BRPI0803636A2 BRPI0803636-5A BRPI0803636A BRPI0803636A2 BR PI0803636 A2 BRPI0803636 A2 BR PI0803636A2 BR PI0803636 A BRPI0803636 A BR PI0803636A BR PI0803636 A2 BRPI0803636 A2 BR PI0803636A2
Authority
BR
Brazil
Prior art keywords
hydrates
synthesis
strontium ranelate
ranelate
strontium
Prior art date
Application number
BRPI0803636-5A
Other languages
English (en)
Inventor
Lucile Vaysse-Ludot
Jean-Pierre Lecouve
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39431194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0803636(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0803636A2 publication Critical patent/BRPI0803636A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Catalysts (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

PROCESSO PARA A SìNTESE DE RANELATO DE ESTRÈNCIO E SEUS HIDRATOS. A presente invenção refere-se a um processo para a síntese industrial de ranelato de estróncio de fórmula (1): e seus hidratos.
BRPI0803636-5A 2007-09-26 2008-09-25 processo para a sìntese de ranelato de estrÈncio e seus hidratos BRPI0803636A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706731A FR2921367B1 (fr) 2007-09-26 2007-09-26 Nouveau procede de synthese du ranelate de strontium et de ses hydrates

Publications (1)

Publication Number Publication Date
BRPI0803636A2 true BRPI0803636A2 (pt) 2009-06-02

Family

ID=39431194

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0803636-5A BRPI0803636A2 (pt) 2007-09-26 2008-09-25 processo para a sìntese de ranelato de estrÈncio e seus hidratos

Country Status (47)

Country Link
US (2) US8063100B2 (pt)
EP (1) EP2042497B1 (pt)
JP (1) JP5016575B2 (pt)
KR (1) KR101099995B1 (pt)
CN (1) CN101397292A (pt)
AP (1) AP2400A (pt)
AR (1) AR068535A1 (pt)
AT (1) ATE460408T1 (pt)
AU (1) AU2008221618B2 (pt)
BR (1) BRPI0803636A2 (pt)
CA (1) CA2640041C (pt)
CL (1) CL2008002833A1 (pt)
CO (1) CO6110143A1 (pt)
CR (1) CR10292A (pt)
CY (1) CY1110036T1 (pt)
DE (1) DE602008000790D1 (pt)
DK (1) DK2042497T3 (pt)
EA (1) EA014247B1 (pt)
EC (1) ECSP088771A (pt)
ES (1) ES2342233T3 (pt)
FR (1) FR2921367B1 (pt)
GE (1) GEP20115191B (pt)
GT (1) GT200800190A (pt)
HN (1) HN2008001490A (pt)
HR (1) HRP20100260T1 (pt)
IL (1) IL194089A (pt)
JO (1) JO2964B1 (pt)
MA (1) MA30319B1 (pt)
ME (1) ME01849B (pt)
MX (1) MX2008012119A (pt)
MY (1) MY144180A (pt)
NI (1) NI200800257A (pt)
NZ (1) NZ571511A (pt)
PA (1) PA8797001A1 (pt)
PE (1) PE20090703A1 (pt)
PL (1) PL2042497T3 (pt)
PT (1) PT2042497E (pt)
RS (1) RS51356B (pt)
SA (1) SA08290594B1 (pt)
SG (1) SG151207A1 (pt)
SI (1) SI2042497T1 (pt)
SV (1) SV2008003033A (pt)
TW (1) TWI358408B (pt)
UA (1) UA97638C2 (pt)
UY (1) UY31341A1 (pt)
WO (1) WO2009074741A2 (pt)
ZA (1) ZA200808176B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
WO2010034806A1 (en) * 2008-09-29 2010-04-01 Ratiopharm Gmbh Anhydrate and hydrate forms of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
IT1398542B1 (it) * 2010-03-05 2013-03-01 Chemelectiva S R L Processo per la preparazione di un polimorfo
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
US20110275834A1 (en) * 2010-05-06 2011-11-10 Divi's Laboratories, Limited Polymorph of strontium ranelate and a process for its preparation
WO2012046251A2 (en) * 2010-10-08 2012-04-12 Glenmark Generics Limited Novel form of ranelic acid
CZ2011320A3 (cs) * 2011-05-30 2012-12-12 Zentiva, K.S. Stabilní krystalická forma X stroncium ranelátu
CN102391247B (zh) * 2011-09-20 2016-12-28 浙江华海药业股份有限公司 一种雷尼酸锶水合物晶形k及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
GB2235691A (en) * 1989-09-04 1991-03-13 Du Pont Canada Concentrates of modifying agents in polymers
JP3880262B2 (ja) * 1998-11-02 2007-02-14 株式会社カネカ 水不溶化再生コラーゲン繊維の製造方法
FR2844795B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2844797B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
US7138529B2 (en) * 2003-04-16 2006-11-21 Hoffmann-La Roche Inc. Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
EP1928855A2 (en) * 2005-08-19 2008-06-11 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
CN100554263C (zh) * 2006-07-19 2009-10-28 天津药物研究院 雷奈酸锶七水合物的制备方法
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates

Also Published As

Publication number Publication date
ME01849B (me) 2011-02-28
ATE460408T1 (de) 2010-03-15
DK2042497T3 (da) 2010-06-07
IL194089A0 (en) 2009-11-18
CA2640041C (fr) 2011-03-08
IL194089A (en) 2016-04-21
HN2008001490A (es) 2010-10-08
AR068535A1 (es) 2009-11-18
ZA200808176B (en) 2010-02-24
KR20090032009A (ko) 2009-03-31
AP2008004617A0 (en) 2008-10-31
CL2008002833A1 (es) 2009-08-07
CO6110143A1 (es) 2009-12-31
NI200800257A (es) 2011-01-12
CA2640041A1 (fr) 2009-03-26
US8063100B2 (en) 2011-11-22
US20120029210A1 (en) 2012-02-02
WO2009074741A3 (fr) 2009-11-26
SG151207A1 (en) 2009-04-30
SV2008003033A (es) 2010-01-21
EA014247B1 (ru) 2010-10-29
JP2009132676A (ja) 2009-06-18
AU2008221618B2 (en) 2012-02-09
HRP20100260T1 (hr) 2010-06-30
GEP20115191B (en) 2011-03-25
AU2008221618A1 (en) 2009-04-09
ES2342233T3 (es) 2010-07-02
FR2921367B1 (fr) 2009-10-30
EP2042497B1 (fr) 2010-03-10
JO2964B1 (en) 2016-03-15
UY31341A1 (es) 2008-10-31
EP2042497A1 (fr) 2009-04-01
PA8797001A1 (es) 2009-09-17
EA200801884A1 (ru) 2009-04-28
DE602008000790D1 (de) 2010-04-22
JP5016575B2 (ja) 2012-09-05
AP2400A (en) 2012-04-30
PE20090703A1 (es) 2009-06-27
UA97638C2 (ru) 2012-03-12
FR2921367A1 (fr) 2009-03-27
NZ571511A (en) 2010-01-29
CR10292A (es) 2008-11-26
PT2042497E (pt) 2010-04-28
WO2009074741A2 (fr) 2009-06-18
TW200920743A (en) 2009-05-16
SA08290594B1 (ar) 2011-02-23
TWI358408B (en) 2012-02-21
KR101099995B1 (ko) 2011-12-28
GT200800190A (es) 2010-05-21
RS51356B (en) 2011-02-28
MX2008012119A (es) 2009-03-25
CY1110036T1 (el) 2015-01-14
ECSP088771A (es) 2009-02-27
US20090082578A1 (en) 2009-03-26
SI2042497T1 (sl) 2010-06-30
MA30319B1 (fr) 2009-04-01
PL2042497T3 (pl) 2010-06-30
CN101397292A (zh) 2009-04-01
MY144180A (en) 2011-08-15

Similar Documents

Publication Publication Date Title
BRPI0803636A2 (pt) processo para a sìntese de ranelato de estrÈncio e seus hidratos
MY162033A (en) New process for the synthesis of agomelatine
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
BRPI0813284A8 (pt) Processo para a preparação de um composto da fórmula (i) e composto
BRPI0905147A8 (pt) processo para síntese de ivabradina e seus sais de adição com um ácido farmaceuticamente aceitável
EA201000257A1 (ru) Новый способ синтеза (7-метокси-l-нафтил) ацетонитрила и применение в синтезе агомелатина
JO2818B1 (en) A new process for the installation of agililatine
MX2009013276A (es) Compuestos anti-inflamatorios de ciclobutenodiona sustituida.
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
CU23757B7 (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
CY1111573T1 (el) Νεα μεθοδος συνθεσης της αγομελατινης
IL206570A0 (en) Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use
UA94604C2 (en) Neuroprotective compounds and uses thereof
BR112013017307A2 (pt) processo de síntese da agomelatina
SG178880A1 (en) Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
NI200900060A (es) Formas de sal de compuestos de benzotienilo sustituidos

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2481 DE 24-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.